Xalkori (crizotinib): Vision disorders, including risk of severe visual loss, need for monitoring in paediatric patients
This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.
|Therapeutic area (MeSH)||
Carcinoma, Non-Small-Cell Lung
|Human ATC code||